🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a mechanistic study in patients with coronary artery disease on th...
Status
Completed
Location
Novartis Investigative Site
Start Date
2014-02-03
Trial ID
NCT01979614
This study will assess the pharmacokinetics of RLX030 during and after admi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-07
Trial ID
NCT01433458
Treatments Being Tested
This study will assess the renal hemodynamic effect of RLX030 infusion in s...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-02
Trial ID
NCT01546532
This was a multinational, multicenter, randomized, open-label study to conf...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-01-31
Trial ID
NCT02064868
Treatments Being Tested
The main purpose of this exploratory study was to investigate the effect of...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-04
Trial ID
NCT01640964
Treatments Being Tested
The study is designed to evaluate the pharmacokinetics, safety and tolerabi...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-08
Trial ID
NCT01875523
Treatments Being Tested
This study is designed in two parts. Part 1 will assess the safety and tole...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2013-05
Trial ID
NCT01566630
Two doses of relaxin will be compared to placebo for the treatment of patie...
Status
Terminated
Location
Russian Scientific Centre of Surgery n.a. B.V.Petrovsky of Russian Academy of Medical Sciences
Start Date
2006-11
Trial ID
NCT00406575
Treatments Being Tested
The purpose of the study was to evaluate the efficacy, safety and tolerabil...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-03-12
Trial ID
NCT02007720
Treatments Being Tested
The purpose of the study was to evaluate the safety, tolerability and pharm...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-09-05
Trial ID
NCT02151383
Treatments Being Tested